UNSPSC 51112523: Sufosfamide

This classification denotes an antipsychotic agent with the molecular formula C8H18ClN2O5PS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2208Y59985, chemically known as 3-(2-chloroethyl)-2-(2-mesyloxyethylamino)tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide but more generally known as sufosfamide, which bears US NIH Compound Identifier 65805. European Medicines Agency schedules Sufosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10672MIG.

UNSPSC 51112523 Sufosfamide is a Commodity code representing a specific pharmaceutical product. State and local governments buy this chemotherapy agent through pharmacy benefit programs and direct pharmaceutical procurement channels. The recent activity under this code reflects state health agencies' exploration of alternative supply and contracting models — specifically, direct-to-manufacturer relationships that bypass traditional pharmacy benefit managers, group purchasing organizations, and wholesalers to improve prescription fulfillment efficiency and manage costs through negotiated net pricing without rebates.

The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) in late March 2026 to solicit vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, with a response deadline of April 3, 2026. The RFI seeks information from potential vendors and stakeholders about their experience with direct contracting for self-insured employers and health plans in both private and government sectors, flexibility to negotiate contracts based on alternative pricing models, and capacity to implement value-based or outcomes-based agreements. This is a preliminary market intelligence phase; the state has not identified award values, budget ranges, or formal evaluation criteria, and plans to use vendor responses to develop detailed specifications and procurement strategy for subsequent formal solicitations. No other state or local opportunities under this code appear in recent records, indicating limited current direct procurement activity for sufosfamide at the state and local level.